Piramal Enterprises drops 11% after poor performance of finserv biz
indiatimes.com
economics
2022-05-27 06:45:00

AgenciesThe pharmaceuticals segment clocked revenue of Rs 2,139.15 crore, while the financial services vertical registered Rs 2,023.79 crore during the quarter, it added.New Delhi: Shares of tumbled about 11 per cent during early trade on Friday after the announcement of earnings in the fourth quarter ended March 31, 2022. Piramal Enterprises reported a consolidated net profit of Rs 150.53 crore in the fourth quarter ended March 31, 2022. It had posted a consolidated net loss of Rs 510.39 crore in the same period previous fiscal.
